Contineum Therapeutics, Inc. Litigation, Intellectual Property, Attorneys, SEC Filings, and Other Public Records

Patent Assignments	20
SEC Filings	185

On PlainSite Chat

No one has posted about Contineum Therapeutics, Inc. yet.

Share something about Contineum Therapeutics, Inc.:

Add a document

Date Recorded	Party	Role	Document Type	Document No.	Invention Title

3/13/2026	Chen, Austin Chih-yu	Assignor	Application	PCT/US2025/0

10/31/2025	Chen, Austin Chih-yu	Assignor	Application	63720561	Methods Of Treating Depression Using A Muscarinic Acetylcholine Receptor...

6/12/2025	Pipeline Therapeutics Inc.	Assignor	Application	PCT/US2024/0	Crystalline Compound Of An Lpar1 Antagonist

6/12/2025	Pipeline Therapeutics Inc.	Assignor	Application	PCT/US2024/0	Crystalline Compound Of An Lpar1 Antagonist

1/10/2025	Chen, Austin Chih-yu	Assignor	Application	63564423	Peripherally Restricted Lpar1 Antagonists And Uses Thereof

1/10/2025	Chen, Austin Chih-yu	Assignor	Application	63564423	Peripherally Restricted Lpar1 Antagonists And Uses Thereof

1/10/2025	Chen, Austin Chih-yu	Assignor	Application	63564423	Peripherally Restricted Lpar1 Antagonists And Uses Thereof

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent	18286088 17762683 15734529 17103455 18225992 17267677 20230089921 20220332721 20210161889 20230364082 20210155629 20240217981 11512090 11752149	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent	18286088 17267677 17762683 15734529 17103455 18225992 20230089921 20220332721 20210161889 20230364082 20240217981 20210155629 12054487 11512090 11752149	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Publication	18294515 20250034110	Lpar1 Antagonists And Uses Thereof Lpar1 Antagonists And Uses Thereof

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application	63481956	Crystalline Compound Of An Lpar1 Antagonist

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Publication Publication Publication Patent Patent Patent	16292050 16470182 15950065 20190194140 20190307746 20180273483 10865188 10925872 10301266	Dibenzo Azepine Compounds And Their Use In The Treatment Of Otic Disease... Methods Of Treating Cochlear Synaptopathy Dibenzo Azepine Compounds And Their Use In The Treatment Of Otic Disease... Dibenzo Azepine Compounds And Their Use In The Treatment Of Otic Disease... Methods Of Treating Cochlear Synaptopathy Dibenzo Azepine Compounds And Their Use In The Treatment Of Otic Disease... Dibenzo Azepine Compounds And Their Use In The Treatment Of Otic Disease... Methods Of Treating Cochlear Synaptopathy Dibenzo Azepine Compounds And Their Use In The Treatment Of Otic Disease...

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	18225992 17762683 18286088 17103455 17267677 15734529 20230089921 20240217981 20210161889 20210155629 20220332721 20230364082 11752149 12054487 11512090 12390462 12565501	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application	PCT/US2022/0 PCT/US2022/0	Lpar1 Antagonists And Uses Thereof Lpar1 Antagonists And Uses Thereof

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application	63481956	Crystalline Compound Of An Lpar1 Antagonist

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application	63481956	Crystalline Compound Of An Lpar1 Antagonist

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	17267677 17762683 18225992 18286088 15734529 17103455 20210155629 20230089921 20230364082 20240217981 20220332721 20210161889 11512090 11752149 12054487 12565501 12390462	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	15734529 17103455 17267677 17762683 18225992 18286088 20210155629 20230089921 20230364082 20240217981 20220332721 20210161889 12054487 12565501 12390462 11512090 11752149	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	17762683 18225992 18286088 15734529 17103455 17267677 20220332721 20210161889 20210155629 20230089921 20230364082 20240217981 12054487 12565501 12390462 11512090 11752149	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

1/18/2024	Pipeline Therapeutics, Inc.	Assignor	Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent Patent	15734529 17103455 17267677 17762683 18225992 18286088 20210155629 20230089921 20230364082 20240217981 20220332721 20210161889 12565501 12390462 11512090 11752149 12054487	Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Crystalline Compound Of Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists Muscarinic Acetylcholine M1 Receptor Antagonists

20 Rows Total

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.

AI text generation	None
AI document summarization	None
AI-augmented search	None
AI-generated images	None
AI chat or Q&A interface	Linkable via MCP
Third party AI contribution in government documents	Possible